Clinical Trial Update: Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating conversion from peginesatide to epoetin alfa in patients receiving hemodialysis; results were posted after the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• Peginesatide (peginesatide)

Snippet

Sponsor: Amgen | Conditions: Anemia | Phase 4 | Status: TERMINATED | Results posted: 2014-04-21